vimarsana.com
Latest Breaking News On - Findings demonstrated - Page 1 : vimarsana.com
Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company's First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases
/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today.
Cambridge
Cambridgeshire
United-kingdom
Joseph-lobacki
Clinical-development-efforts
Prnewswire-artax-biopharma-inc
Findings-demonstrated
Investigational-agent
Well-tolerated
All-doses
Strongly-supports-further-clinical-development
Being-developed
vimarsana © 2020. All Rights Reserved.